Key Takeaways:
- Clinicians advise against stopping menopausal estradiol abruptly during pharmacy backorders, as sudden withdrawal triggers rebound hot flashes, insomnia, mood dips, and brain fog.
- Transdermal estradiol pump gel, single-dose gel sachets, transdermal sprays, and matrix skin patches all deliver identical 17-beta-estradiol through the skin with matching VTE safety.
- Standard clinical dose-equivalence charts map 1–4 gel pumps cleanly onto 25–100 mcg patches, 0.5–2 mg gel sachets, and 1–3+ metered transdermal sprays.
- For postmenopausal women on continuous combined therapy who prefer a single daily pill, combined body-identical estradiol + micronized progesterone capsules (Bijuva/Bijuve) offer a lower-risk oral option than older synthetic progestins.
Transdermal Estradiol Dose-Equivalence Reference Table
Always confirm any formulation switch with your prescribing clinician—individual skin absorption varies slightly, so symptoms guide fine-tuning—but standard menopause-society equivalence guidelines align as follows:
| Dose Tier | Estradiol Patch | Metered Gel Pump (0.06%) | Single-Dose Gel Sachet | Transdermal Spray (1.53 mg/spray) |
|---|---|---|---|---|
| Ultra-Low | 12.5–14 mcg (or half 25 mcg matrix patch) | ½ pump daily | Half of 0.5 mg sachet | — |
| Low | 25 mcg patch |
1 pump daily |
0.5 mg sachet daily |
1–2 sprays daily |
| Standard | 50 mcg patch |
2 pumps daily |
1.0 mg sachet daily |
2–3 sprays daily |
| Moderate–High | 75–100 mcg patch |
3–4 pumps daily |
1.5–2.0 mg daily |
3+ sprays (per clinician review) |
Remember Uterine Progesterone Protection & Combined Bioidentical Capsules
If you have a uterus and switch from one estrogen-only gel/patch/spray to another, keep taking your separate micronized progesterone (or maintain your progestin IUD) without interruption. Postmenopausal patients seeking an all-in-one oral alternative can also discuss fixed-dose body-identical 17-beta-estradiol + micronized progesterone capsules with their clinician.
Leave a Reply